Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations.

The Journal of Clinical Investigation
R SilberD Zucker-Franklin

Abstract

The enzyme, 5'-nucleotidase (5'N) (E.C.-3.1.3.5) is present in lymphocytes isolated from the blood of normal subjects. This activity is markedly decreased or not detectable in the cells from three-quarters of patients with chronic lymphocytic leukemia (CLL), while supranormal levels are found in less than 10% of the cases. To determine whether the decreased 5'N value in CLL represents a lower activity per cell or fewer enzyme-containing cells than in the normal, conditions were established for the histochemical measurement of 5'N in human lymphocytes. It was found that the cells isolated from the blood of normal subjects or patients with CLL consist of 5'N-positive and 5'N-negative subpopulations. Normal subjects who had high 5'N specific activity were shown to have a greater percentage of 5'N-positive cells than individuals with low 5'N activity. Patients with CLL who had no activity by standard chemical assay had no 5'N-positive cells, while the exceptional patient with CLL with a higher than normal specific activity showed an percentage of 5'N-positive cells. It is suggested that the selective proliferation of 5'N-positive and 5'N-negative populations may account for the heterogeneity of 5'N in CLL.

References

Jun 13, 1975·Annals of the New York Academy of Sciences·M L KarnovskyA Harper
Apr 19, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·D Marique, J Hildebrand
May 1, 1973·The Journal of Clinical Investigation·J LopesR Silber

❮ Previous
Next ❯

Citations

May 1, 1990·American Journal of Hematology·R InvernizziE Ascari
Jul 1, 1981·The Histochemical Journal·R J Uusitalo
Jan 1, 1983·The International Journal of Biochemistry·K K McMahonA G Fischer
Dec 1, 1986·Veterinary Immunology and Immunopathology·U M Sarmiento, V E Valli
Aug 31, 2001·European Journal of Pharmacology·A D ConigraveJ S Wiley
Dec 1, 1977·The Journal of Experimental Medicine·W D JohnsonZ A Cohn
Apr 29, 1998·Immunological Reviews·R RestaL F Thompson
Jan 3, 1983·Klinische Wochenschrift·W GutensohnB Emmerich
Jan 1, 1983·Leukemia Research·J P van Laarhoven, C H de Bruyn
Jan 1, 1983·Leukemia Research·E El-Mohandes, F G Hayhoe
Jan 1, 1985·Critical Reviews in Oncology/hematology·E Thiel
Jan 1, 1985·Critical Reviews in Oncology/hematology·P Rambotti, S Davis
Oct 1, 1980·Immunology Today·J C Cawley, G F Burns
Jan 1, 1979·Medical and Pediatric Oncology·G SpanosH W Grünwald
Jun 1, 1983·Acta Ophthalmologica·R J UusitaloA Palkama
Jan 1, 1983·Clinical and Laboratory Haematology·E A El-Mohandes, F G Hayhoe
Oct 27, 2017·Cancer Immunology Research·Frederik WeinRalf Küppers
Mar 1, 1979·Clinical Immunology and Immunopathology·R J KanterA Sawitsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.